# Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?

> **NCT02237339** · PHASE4 · COMPLETED · sponsor: **University of Dundee** · enrollment: 72 (actual)

## Conditions studied

- Hypertension
- Hypertrophy, Left Ventricular

## Interventions

- **DRUG:** Allopurinol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02237339
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2019-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237339, "Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02237339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*